BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...
MPS Art Therapy presents a talk with Pamela Harmell, PhD, on preventing boundary violations in the therapy relationship. Therapeutic boundaries define the roles and limitations of the therapist-client ...
With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, raising $257 million in a series ...
Claroty has secured $150 million in a Series F funding round to support global expansion and continued development of its cyber-physical systems, or CPS, security platform as demand grows for critical ...
Haider is a writer and editor with years of experience and has been a fan of GameRant for years due to its great content. As an anime features writer for the site, he theorizes about the latest anime ...
CAMBRIDGE, Mass., Jan. 7, 2026 /PRNewswire/ -- STRM.BIO, a biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced $8 million in Series Seed ...
Fond of weirdly obscure titles since childhood, Ivanir has been captivated by many Japanese games over the years. Some of his most passionate topics are the Dept. Heaven series, Summon Night ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--MindImmune Therapeutics, a private company developing new treatments targeting the inflammatory drivers of neurodegenerative disease, today announced two major ...
MINTROCKET has released an Xbox Series version of single-player adventure RPG DAVE THE DIVER via Microsoft Store for $19.99, the developer announced. The PC version is also now available via Microsoft ...
Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The ...
Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not been established. We randomly assigned participants 45 to 85 years of age ...
Please provide your email address to receive an email when new articles are posted on . “Despite several clinical practice guidelines recommending non-pharmacological treatments as frontline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results